Cobomarsen Uses, Dosage, Side Effects and more
Cobomarsen is under investigation in clinical trial NCT02580552 (Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL).
| Trade Name | Cobomarsen |
| Generic | Cobomarsen |
| Cobomarsen Other Names | Cobomarsen |
| Type | |
| Formula | C148H177N52O77P13S13 |
| Weight | Average: 4735.77 Monoisotopic: 4732.449135883 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
